116 related articles for article (PubMed ID: 11553889)
1. Crosslink formation in porcine valves stabilized by dye-mediated photooxidation.
Adams AK; Talman EA; Campbell L; McIlroy BK; Moore MA
J Biomed Mater Res; 2001 Dec; 57(4):582-7. PubMed ID: 11553889
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of porcine valves prepared by dye-mediated photooxidation.
Moore MA; Phillips RE; McIlroy BK; Walley VM; Hendry PJ
Ann Thorac Surg; 1998 Dec; 66(6 Suppl):S245-8. PubMed ID: 9930457
[TBL] [Abstract][Full Text] [Related]
3. Biocompatibility and immunologic properties of pericardial tissue stabilized by dye-mediated photooxidation.
Moore MA; Phillips RE
J Heart Valve Dis; 1997 May; 6(3):307-15. PubMed ID: 9183731
[TBL] [Abstract][Full Text] [Related]
4. Chemical modification of bovine tissues by dye-mediated photooxidation.
McIlroy BK; Robinson MD; Chen WM; Moore MA
J Heart Valve Dis; 1997 Jul; 6(4):416-23. PubMed ID: 9263875
[TBL] [Abstract][Full Text] [Related]
5. Calcification resistance, biostability, and low immunogenic potential of porcine heart valves modified by dye-mediated photooxidation.
Moore MA; Adams AK
J Biomed Mater Res; 2001 Jul; 56(1):24-30. PubMed ID: 11309787
[TBL] [Abstract][Full Text] [Related]
6. Stabilization of pericardial tissue by dye-mediated photooxidation.
Moore MA; Bohachevsky IK; Cheung DT; Boyan BD; Chen WM; Bickers RR; McIlroy BK
J Biomed Mater Res; 1994 May; 28(5):611-8. PubMed ID: 8027101
[TBL] [Abstract][Full Text] [Related]
7. Mechanisms of the in vivo inhibition of calcification of bioprosthetic porcine aortic valve cusps and aortic wall with triglycidylamine/mercapto bisphosphonate.
Rapoport HS; Connolly JM; Fulmer J; Dai N; Murti BH; Gorman RC; Gorman JH; Alferiev I; Levy RJ
Biomaterials; 2007 Feb; 28(4):690-9. PubMed ID: 17027944
[TBL] [Abstract][Full Text] [Related]
8. [Crosslinking bovine pericardial bioprosthetic heart valves by phthalocyanine sensitized photooxidation reaction].
Lin L; Tang YW; Liang Q; Zhou JY; Cui JW; Hu SS; Zhang FS
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2003 Dec; 25(6):671-5. PubMed ID: 14714309
[TBL] [Abstract][Full Text] [Related]
9. Shrinkage temperature versus protein extraction as a measure of stabilization of photooxidized tissue.
Moore MA; Chen WM; Phillips RE; Bohachevsky IK; McIlroy BK
J Biomed Mater Res; 1996 Oct; 32(2):209-14. PubMed ID: 8884497
[TBL] [Abstract][Full Text] [Related]
10. ADAPT-treated porcine valve tissue (cusp and wall) versus Medtronic Freestyle and Prima Plus: crosslink stability and calcification behavior in the subcutaneous rat model.
Neethling WM; Glancy R; Hodge AJ
J Heart Valve Dis; 2004 Jul; 13(4):689-96; discussion 696. PubMed ID: 15311879
[TBL] [Abstract][Full Text] [Related]
11. [Morphologic and physiochemical properties of bovine jugular conduit stabilized by dye-mediated poto-oxidation].
Feng YG; Wu ZS; Hu JG; Hu TH; Zhang JC; Xu ZJ; Wang H; Ma ZX
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2004 Aug; 29(4):429-31. PubMed ID: 16134596
[TBL] [Abstract][Full Text] [Related]
12. Glycosaminoglycan-degrading enzymes in porcine aortic heart valves: implications for bioprosthetic heart valve degeneration.
Simionescu DT; Lovekamp JJ; Vyavahare NR
J Heart Valve Dis; 2003 Mar; 12(2):217-25. PubMed ID: 12701795
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of a novel tetra-functional branched poly(ethylene glycol) crosslinker for manufacture of crosslinked, decellularized, porcine aortic valve leaflets.
Hu XJ; Dong NG; Shi JW; Deng C; Li HD; Lu CF
J Biomed Mater Res B Appl Biomater; 2014 Feb; 102(2):322-36. PubMed ID: 24115395
[TBL] [Abstract][Full Text] [Related]
14. Effects of fixation back pressure and antimineralization treatment on the morphology of porcine aortic bioprosthetic valves.
Flomenbaum MA; Schoen FJ
J Thorac Cardiovasc Surg; 1993 Jan; 105(1):154-64. PubMed ID: 8419696
[TBL] [Abstract][Full Text] [Related]
15. Mechanism of efficacy of 2-amino oleic acid for inhibition of calcification of glutaraldehyde-pretreated porcine bioprosthetic heart valves.
Chen W; Schoen FJ; Levy RJ
Circulation; 1994 Jul; 90(1):323-9. PubMed ID: 8026014
[TBL] [Abstract][Full Text] [Related]
16. Prevention of bioprosthetic heart valve calcification by ethanol preincubation. Efficacy and mechanisms.
Vyavahare N; Hirsch D; Lerner E; Baskin JZ; Schoen FJ; Bianco R; Kruth HS; Zand R; Levy RJ
Circulation; 1997 Jan; 95(2):479-88. PubMed ID: 9008467
[TBL] [Abstract][Full Text] [Related]
17. The influence of stenting on the behavior of amino-oleic acid-treated, glutaraldehyde-fixed porcine aortic valves in a sheep model.
Ozaki S; Herijgers P; Verbeken E; Van Lommel A; Nishida T; Perek B; Zietkiewicz M; Leunens V; Flameng W
J Heart Valve Dis; 2000 Jul; 9(4):552-9; discussion 559-60. PubMed ID: 10947049
[TBL] [Abstract][Full Text] [Related]
18. [Using chemical methods to crosslink xenogeneic heart valves: the progress of bioprosthetic heart valves].
Lin L; Tang YW; Chang R; Zhou JY; Cui JW; Hu SS; Zhang FS
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2003 Dec; 25(6):735-7. PubMed ID: 14714325
[TBL] [Abstract][Full Text] [Related]
19. Calcification resistance of procyanidin-treated decellularized porcine aortic valves in vivo.
Liu Y; Liu W; Sun G; Wei X; Yi D
Heart Surg Forum; 2009 Jan; 12(1):E24-9. PubMed ID: 19233761
[TBL] [Abstract][Full Text] [Related]
20. Mechanical properties of a porcine aortic valve fixed with a naturally occurring crosslinking agent.
Sung HW; Chang Y; Chiu CT; Chen CN; Liang HC
Biomaterials; 1999 Oct; 20(19):1759-72. PubMed ID: 10509186
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
